Page 114 - The Effect of Hydrogen and Hydrides - ebook first test
P. 114

Table 4-7:   Test matrix for PWR cladding:

                  (a) Irradiated PWR-48GWd/t-type Zircaloy-4; (b) irradiated PWR-39GWd/t- type Zircaloy-4; (c) irradiated
                             PWR-55GWd/t-type MDA and ZIRLO.

                  A: hydride reorientation test (constant hoop stress) and B: ring compression test.

                      Temperature    Cooling                        Hoop stress (MPa)
                                      rate

                   (a)  (C)   (K)   (C/h)     0 (heat treatment   85   100   115   130   As-irradiated (no heat
                                                 without stress)                             treatment)
                        340   613      30            . . .       . . .   A+B   . . .   A+B      B
                        300   573                   A+B          A+B  A+B    A   A+B

                        275   548                    A           . . .   A+B  A+B   A+B
                        250   523                    . . .       . . .   A+B   . . .   A+B
                        300   573      3            A+B          . . .   ___  A+B   A
                                      0.6            . . .       . . .   ___  A+B   . . .

                   (b   Temperature   Cooling                       Hoop stress (MPa)
                    )                 rate
                       (C)   (K)    (C/h)     0 (heat treatment   80   100   115   130   As-irradiated (no heat
                                                 without stress)                             treatment)
                        300   573      30            . . .       . . .   . . .   . . .   A     . . .
                   (c)   Temperature   Cooling                      Hoop stress (MPa)
                                      rate
                       (C)   (K)    (C/h)     0 (heat treatment   80   100   115   130   As-irradiated (no heat
                                                 without stress)                             treatment)

                        300   573      30            . . .       . . .   . . .   A   A         . . .
                                                                                           © ANT International 2018





































                                   Copyright © Advanced Nuclear Technology International Europe AB, ANT International, 2019.
   109   110   111   112   113   114   115   116   117   118   119